ID   ENOG_HUMAN              Reviewed;         434 AA.
AC   P09104; B7Z2X9; Q96J33;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 189.
DE   RecName: Full=Gamma-enolase;
DE            EC=4.2.1.11;
DE   AltName: Full=2-phospho-D-glycerate hydro-lyase;
DE   AltName: Full=Enolase 2;
DE   AltName: Full=Neural enolase;
DE   AltName: Full=Neuron-specific enolase;
DE            Short=NSE;
GN   Name=ENO2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Retina;
RX   PubMed=3208766; DOI=10.1111/j.1432-1033.1988.tb14465.x;
RA   McAleese S.M., Dunbar B., Fothergill J., Hinks L., Day I.N.M.;
RT   "Complete amino acid sequence of the neurone-specific gamma isozyme of
RT   enolase (NSE) from human brain and comparison with the non-neuronal
RT   alpha form (NNE).";
RL   Eur. J. Biochem. 178:413-417(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=3385803; DOI=10.1002/jnr.490190409;
RA   van Obberghen E., Kamholz J., Bishop J.G. III, Zomzely-Neurath C.,
RA   Lazzarini R.A.;
RT   "Human gamma enolase: isolation of a cDNA clone and expression in
RT   normal and tumor tissues of human origin.";
RL   J. Neurosci. Res. 19:450-456(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2792767; DOI=10.1016/0378-1119(89)90217-5;
RA   Oliva D., Barba G., Barbieri G., Giallongo A., Feo S.;
RT   "Cloning, expression and sequence homologies of cDNA for human gamma
RT   enolase.";
RL   Gene 79:355-360(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Hematopoietic;
RX   PubMed=2045099; DOI=10.1016/0888-7543(91)90496-2;
RA   Oliva D., Cali L., Feo S., Giallongo A.;
RT   "Complete structure of the human gene encoding neuron-specific
RT   enolase.";
RL   Genomics 10:157-165(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Brain;
RX   PubMed=9074930; DOI=10.1101/gr.7.3.268;
RA   Ansari-Lari M.A., Shen Y., Muzny D.M., Lee W., Gibbs R.A.;
RT   "Large-scale sequencing in human chromosome 12p13: experimental and
RT   computational gene structure determination.";
RL   Genome Res. 7:268-280(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Caudate nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 16-28; 33-50; 90-103; 163-179; 184-193; 240-262;
RP   270-285; 336-372 AND 413-422, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 425-434 (ISOFORM 1/2).
RX   PubMed=3653393; DOI=10.1016/0014-5793(87)80207-7;
RA   Day I.N.M., Allsopp M.T.E.P., Moore D.C.M., Thompson R.J.;
RT   "Sequence conservation in the 3'-untranslated regions of neurone-
RT   specific enolase, lymphokine and protooncogene mRNAs.";
RL   FEBS Lett. 222:139-143(1987).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-44, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-26, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS.
RX   PubMed=15289101; DOI=10.1016/j.jmb.2004.05.068;
RA   Chai G., Brewer J.M., Lovelace L.L., Aoki T., Minor W., Lebioda L.;
RT   "Expression, purification and the 1.8 angstroms resolution crystal
RT   structure of human neuron specific enolase.";
RL   J. Mol. Biol. 341:1015-1021(2004).
CC   -!- FUNCTION: Has neurotrophic and neuroprotective properties on a
CC       broad spectrum of central nervous system (CNS) neurons. Binds, in
CC       a calcium-dependent manner, to cultured neocortical neurons and
CC       promotes cell survival (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: 2-phospho-D-glycerate = phosphoenolpyruvate +
CC       H(2)O.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Mg(2+) is required for catalysis and for stabilizing the
CC       dimer.;
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-
CC       glyceraldehyde 3-phosphate: step 4/5.
CC   -!- SUBUNIT: Mammalian enolase is composed of 3 isozyme subunits,
CC       alpha, beta and gamma, which can form homodimers or heterodimers
CC       which are cell-type and development-specific.
CC       {ECO:0000269|PubMed:15289101}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}. Note=Can translocate to the plasma membrane in
CC       either the homodimeric (alpha/alpha) or heterodimeric
CC       (alpha/gamma) form. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P09104-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P09104-2; Sequence=VSP_055482;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: The alpha/alpha homodimer is expressed in
CC       embryo and in most adult tissues. The alpha/beta heterodimer and
CC       the beta/beta homodimer are found in striated muscle, and the
CC       alpha/gamma heterodimer and the gamma/gamma homodimer in neurons.
CC   -!- DEVELOPMENTAL STAGE: During ontogenesis, there is a transition
CC       from the alpha/alpha homodimer to the alpha/beta heterodimer in
CC       striated muscle cells, and to the alpha/gamma heterodimer in nerve
CC       cells.
CC   -!- INDUCTION: Levels of ENO2 increase dramatically in cardiovascular
CC       accidents, cerebral trauma, brain tumors and Creutzfeldt-Jakob
CC       disease.
CC   -!- SIMILARITY: Belongs to the enolase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52388.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X13120; CAA31512.1; -; mRNA.
DR   EMBL; X14327; CAA32505.1; -; mRNA.
DR   EMBL; M36768; AAA52388.1; ALT_INIT; mRNA.
DR   EMBL; M22349; AAB59554.1; -; mRNA.
DR   EMBL; X51956; CAA36215.1; -; Genomic_DNA.
DR   EMBL; AK295220; BAH12015.1; -; mRNA.
DR   EMBL; BT007383; AAP36047.1; -; mRNA.
DR   EMBL; U47924; AAB51320.1; -; Genomic_DNA.
DR   EMBL; BC002745; AAH02745.1; -; mRNA.
DR   CCDS; CCDS8570.1; -. [P09104-1]
DR   PIR; JU0060; NOHUG.
DR   RefSeq; NP_001966.1; NM_001975.2. [P09104-1]
DR   UniGene; Hs.511915; -.
DR   PDB; 1TE6; X-ray; 1.80 A; A/B=2-434.
DR   PDB; 2AKM; X-ray; 1.92 A; A/B=2-434.
DR   PDB; 2AKZ; X-ray; 1.36 A; A/B=2-434.
DR   PDB; 3UCC; X-ray; 1.50 A; A/B=2-434.
DR   PDB; 3UCD; X-ray; 1.41 A; A/B=2-434.
DR   PDB; 3UJE; X-ray; 1.55 A; A/B=2-434.
DR   PDB; 3UJF; X-ray; 2.10 A; A/B=2-434.
DR   PDB; 3UJR; X-ray; 1.40 A; A/B=2-434.
DR   PDB; 3UJS; X-ray; 1.65 A; A/B=2-434.
DR   PDBsum; 1TE6; -.
DR   PDBsum; 2AKM; -.
DR   PDBsum; 2AKZ; -.
DR   PDBsum; 3UCC; -.
DR   PDBsum; 3UCD; -.
DR   PDBsum; 3UJE; -.
DR   PDBsum; 3UJF; -.
DR   PDBsum; 3UJR; -.
DR   PDBsum; 3UJS; -.
DR   ProteinModelPortal; P09104; -.
DR   SMR; P09104; 2-434.
DR   BioGrid; 108340; 41.
DR   IntAct; P09104; 22.
DR   MINT; MINT-1367862; -.
DR   STRING; 9606.ENSP00000229277; -.
DR   PhosphoSite; P09104; -.
DR   BioMuta; ENO2; -.
DR   DMDM; 20981682; -.
DR   OGP; P09104; -.
DR   UCD-2DPAGE; P09104; -.
DR   MaxQB; P09104; -.
DR   PaxDb; P09104; -.
DR   PRIDE; P09104; -.
DR   DNASU; 2026; -.
DR   Ensembl; ENST00000229277; ENSP00000229277; ENSG00000111674.
DR   Ensembl; ENST00000535366; ENSP00000437402; ENSG00000111674.
DR   Ensembl; ENST00000538763; ENSP00000441490; ENSG00000111674. [P09104-2]
DR   Ensembl; ENST00000541477; ENSP00000438873; ENSG00000111674.
DR   GeneID; 2026; -.
DR   KEGG; hsa:2026; -.
DR   UCSC; uc001qru.1; human. [P09104-1]
DR   UCSC; uc010sfq.1; human.
DR   CTD; 2026; -.
DR   GeneCards; GC12P007149; -.
DR   HGNC; HGNC:3353; ENO2.
DR   HPA; CAB000063; -.
DR   HPA; HPA068284; -.
DR   MIM; 131360; gene.
DR   neXtProt; NX_P09104; -.
DR   PharmGKB; PA27788; -.
DR   eggNOG; COG0148; -.
DR   GeneTree; ENSGT00550000074560; -.
DR   HOGENOM; HOG000072174; -.
DR   HOVERGEN; HBG000067; -.
DR   InParanoid; P09104; -.
DR   KO; K01689; -.
DR   OMA; EAYAGNQ; -.
DR   PhylomeDB; P09104; -.
DR   TreeFam; TF300391; -.
DR   BioCyc; MetaCyc:HS10646-MONOMER; -.
DR   BRENDA; 4.2.1.11; 2681.
DR   Reactome; REACT_1383; Glycolysis.
DR   Reactome; REACT_1520; Gluconeogenesis.
DR   SABIO-RK; P09104; -.
DR   UniPathway; UPA00109; UER00187.
DR   ChiTaRS; ENO2; human.
DR   EvolutionaryTrace; P09104; -.
DR   GeneWiki; Enolase_2; -.
DR   GenomeRNAi; 2026; -.
DR   NextBio; 35479101; -.
DR   PMAP-CutDB; P09104; -.
DR   PRO; PR:P09104; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; P09104; -.
DR   CleanEx; HS_ENO2; -.
DR   ExpressionAtlas; P09104; baseline and differential.
DR   Genevisible; P09104; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0000015; C:phosphopyruvate hydratase complex; IEA:InterPro.
DR   GO; GO:0001917; C:photoreceptor inner segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004634; F:phosphopyruvate hydratase activity; TAS:ProtInc.
DR   GO; GO:0061621; P:canonical glycolysis; TAS:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:Reactome.
DR   GO; GO:0006094; P:gluconeogenesis; TAS:Reactome.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:Reactome.
DR   GO; GO:0044281; P:small molecule metabolic process; TAS:Reactome.
DR   Gene3D; 3.20.20.120; -; 1.
DR   Gene3D; 3.30.390.10; -; 1.
DR   HAMAP; MF_00318; Enolase; 1.
DR   InterPro; IPR000941; Enolase.
DR   InterPro; IPR020810; Enolase_C.
DR   InterPro; IPR029065; Enolase_C-like.
DR   InterPro; IPR020809; Enolase_CS.
DR   InterPro; IPR020811; Enolase_N.
DR   InterPro; IPR029017; Enolase_N-like.
DR   PANTHER; PTHR11902; PTHR11902; 1.
DR   Pfam; PF00113; Enolase_C; 1.
DR   Pfam; PF03952; Enolase_N; 1.
DR   PIRSF; PIRSF001400; Enolase; 1.
DR   PRINTS; PR00148; ENOLASE.
DR   SUPFAM; SSF51604; SSF51604; 1.
DR   SUPFAM; SSF54826; SSF54826; 1.
DR   TIGRFAMs; TIGR01060; eno; 1.
DR   PROSITE; PS00164; ENOLASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell membrane;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Glycolysis;
KW   Lyase; Magnesium; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P06733}.
FT   CHAIN         2    434       Gamma-enolase.
FT                                /FTId=PRO_0000134112.
FT   REGION      370    373       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    210    210       Proton donor. {ECO:0000250}.
FT   ACT_SITE    343    343       Proton acceptor. {ECO:0000250}.
FT   METAL       245    245       Magnesium.
FT   METAL       293    293       Magnesium.
FT   METAL       318    318       Magnesium.
FT   BINDING     158    158       Substrate. {ECO:0000250}.
FT   BINDING     167    167       Substrate. {ECO:0000250}.
FT   BINDING     293    293       Substrate. {ECO:0000250}.
FT   BINDING     318    318       Substrate. {ECO:0000250}.
FT   BINDING     394    394       Substrate. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES       5      5       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES      26     26       Phosphothreonine.
FT                                {ECO:0000269|PubMed:20068231}.
FT   MOD_RES      44     44       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:15592455}.
FT   MOD_RES      60     60       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES      60     60       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES      64     64       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES      89     89       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES      89     89       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES     193    193       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     197    197       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17183}.
FT   MOD_RES     199    199       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17183}.
FT   MOD_RES     202    202       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES     228    228       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     228    228       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES     233    233       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     256    256       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     263    263       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     287    287       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     291    291       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06733}.
FT   MOD_RES     335    335       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES     343    343       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   MOD_RES     406    406       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P17182}.
FT   VAR_SEQ      61    104       GVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTE
FT                                NKS -> A (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055482.
FT   VARIANT     264    264       P -> A.
FT                                /FTId=VAR_002354.
FT   VARIANT     395    395       T -> A.
FT                                /FTId=VAR_002355.
FT   CONFLICT      4      4       E -> Q (in Ref. 1; CAA31512/CAA32505).
FT                                {ECO:0000305}.
FT   CONFLICT     27     28       AK -> GC (in Ref. 2; AAA52388).
FT                                {ECO:0000305}.
FT   CONFLICT    127    127       E -> N (in Ref. 2; AAA52388).
FT                                {ECO:0000305}.
FT   CONFLICT    240    240       I -> M (in Ref. 1; CAA31512/CAA32505).
FT                                {ECO:0000305}.
FT   STRAND        5     12       {ECO:0000244|PDB:2AKZ}.
FT   STRAND       18     26       {ECO:0000244|PDB:2AKZ}.
FT   STRAND       29     34       {ECO:0000244|PDB:2AKZ}.
FT   HELIX        57     59       {ECO:0000244|PDB:2AKZ}.
FT   HELIX        63     71       {ECO:0000244|PDB:2AKZ}.
FT   HELIX        73     80       {ECO:0000244|PDB:2AKZ}.
FT   HELIX        87     98       {ECO:0000244|PDB:2AKZ}.
FT   TURN        104    106       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       108    126       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       130    138       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      147    154       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       156    158       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      159    162       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      167    171       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       178    200       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       202    205       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      211    213       {ECO:0000244|PDB:3UJF}.
FT   HELIX       220    234       {ECO:0000244|PDB:2AKZ}.
FT   TURN        237    239       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      241    245       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       248    251       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      254    257       {ECO:0000244|PDB:2AKM}.
FT   TURN        259    262       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       267    269       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       273    286       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      289    293       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       301    309       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      312    318       {ECO:0000244|PDB:2AKZ}.
FT   TURN        319    323       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       325    333       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      338    342       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       344    347       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       350    362       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      366    370       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       380    388       {ECO:0000244|PDB:2AKZ}.
FT   STRAND      391    394       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       401    417       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       418    420       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       425    427       {ECO:0000244|PDB:2AKZ}.
FT   HELIX       431    433       {ECO:0000244|PDB:2AKZ}.
SQ   SEQUENCE   434 AA;  47269 MW;  6163DE81F5C67744 CRC64;
     MSIEKIWARE ILDSRGNPTV EVDLYTAKGL FRAAVPSGAS TGIYEALELR DGDKQRYLGK
     GVLKAVDHIN STIAPALISS GLSVVEQEKL DNLMLELDGT ENKSKFGANA ILGVSLAVCK
     AGAAERELPL YRHIAQLAGN SDLILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAESFRD
     AMRLGAEVYH TLKGVIKDKY GKDATNVGDE GGFAPNILEN SEALELVKEA IDKAGYTEKI
     VIGMDVAASE FYRDGKYDLD FKSPTDPSRY ITGDQLGALY QDFVRDYPVV SIEDPFDQDD
     WAAWSKFTAN VGIQIVGDDL TVTNPKRIER AVEEKACNCL LLKVNQIGSV TEAIQACKLA
     QENGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL MRIEEELGDE
     ARFAGHNFRN PSVL
//
